The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Phosphonol     2-(3-methylaminopropylamino) ethylsulfanylp...

Synonyms: CHEMBL159688, WR-3689, NSC-327729, LS-66014, NSC327729, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of WR 3689

 

High impact information on WR 3689

  • These results suggest that WR-3689 can affect catecholamine metabolism in the mouse hypothalamus, but the mode of action is not clear [2].
  • For the bone marrow syndrome (LD50/30) the neutron DMFs were 1.47 for WR-3689 and 1.21 for WR-77913 [3].
  • Next, the effect of WR-3689 on the survival of jejunal stem cells was determined by assaying the survival of mice given X-ray doses to the whole abdomen in the range leading to death from the gastrointestinal syndrome [4].
  • Protection by WR-3689 against gamma-ray-induced intestinal damage: comparative effect on clonogenic cell survival, mouse survival, and DNA damage [4].
  • Protection factors (PFs) were obtained by measuring survival curves for clonogenic crypt cells as a function of radiation dose; WR-3689 given 30 min before whole-body irradiation protected jejunum in the microcolony assay with a PF of 1.26 +/- 0.02, 1.50 +/- 0.10, and 1.65 +/- 0.10 at doses of 200, 400, and 800 mg/kg, respectively [4].
 

Chemical compound and disease context of WR 3689

  • Recent evidence indicates that administration of the CNS stimulant caffeine mitigates the behavioral toxicity of an effective radioprotective dose of the phosphorothioate WR-3689 without altering its radioprotective efficacy [5].
  • This overview summarizes the studies on the behavioral toxicity of selected radioprotectors classified as phosphorothioates (WR-2721, WR-3689), bioactive lipids (16, 16 dimethylprostaglandin E2(DiPGE2), platelet activating factor (PAF), leukotriene C4), and immunomodulators (glucan, synthetic trehalose dicorynomycolate, and interleukin-1) [6].
 

Anatomical context of WR 3689

 

Associations of WR 3689 with other chemical compounds

 

Analytical, diagnostic and therapeutic context of WR 3689

  • When WR-3689 was administered 30 min prior to whole-body irradiation, the number of surviving crypt cells was markedly increased at all doses of the drug, although protection began to level out at doses larger than 600 mg/kg [4].
  • Synthesis, biodistribution, and autoradiography of radiolabeled S-2-(3-methylaminopropylamino)ethylphosphorothioic acid (WR-3689) [8].

References

  1. Modification of neutron-induced hematopoietic effects by chemical radioprotectors. Sigdestad, C.P., Connor, A.M., Sims, C.S. Int. J. Radiat. Oncol. Biol. Phys. (1992) [Pubmed]
  2. Effects of S-2-(3-methylaminopropylamino)ethyl phosphorothioic acid (WR-3689), alone or combined with caffeine, on catecholamine content of mouse hypothalamus. Palazzolo, D.L., Kumar, K.S. Proc. Soc. Exp. Biol. Med. (1993) [Pubmed]
  3. Response of mouse tissues to neutron and gamma radiation: protection by WR-3689 and WR-77913. Rasey, J.S., Magee, S., Nelson, N., Chin, L., Krohn, K.A. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. (1990) [Pubmed]
  4. Protection by WR-3689 against gamma-ray-induced intestinal damage: comparative effect on clonogenic cell survival, mouse survival, and DNA damage. Murray, D., Altschuler, E.M., Hunter, N., Milas, L. Radiat. Res. (1989) [Pubmed]
  5. Advances in radioprotection through the use of combined agent regimens. Weiss, J.F., Kumar, K.S., Walden, T.L., Neta, R., Landauer, M.R., Clark, E.P. Int. J. Radiat. Biol. (1990) [Pubmed]
  6. Behavioral toxicity of selected radioprotectors. Landauer, M.R., Davis, H.D., Kumar, K.S., Weiss, J.F. Advances in space research : the official journal of the Committee on Space Research (COSPAR). (1992) [Pubmed]
  7. Comparison of the protective effects of three phosphorothioate radioprotectors in the RIF-1 tumor. Rasey, J.S., Krohn, K.A., Magee, S., Nelson, N., Chin, L. Radiat. Res. (1986) [Pubmed]
  8. Synthesis, biodistribution, and autoradiography of radiolabeled S-2-(3-methylaminopropylamino)ethylphosphorothioic acid (WR-3689). Rasey, J.S., Krohn, K.A., Grunbaum, Z., Spence, A.M., Menard, T.W., Wade, R.A. Radiat. Res. (1986) [Pubmed]
 
WikiGenes - Universities